631823873	631823873	CD	B-NP	O
|	|	NN	I-NP	O
KMH	KMH	NN	I-NP	O
|	|	NN	I-NP	O
09473534	09473534	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1831540	1831540	CD	B-NP	O
|	|	CC	I-NP	O
2/2/2006	2/2/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/18/2006	4/18/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/25/2006	5/25/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
HAEBER	HAEBER	NNP	B-NP	O
,	,	,	O	O
VINCENT	VINCENT	NNP	B-NP	O
172-58-05-1	172-58-05-1	CD	I-NP	O
Bay	Bay	NNP	I-NP	O
Wayne	Wayne	NNP	I-NP	O
Sno	Sno	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/1/06	10/1/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KLINKENBERG	KLINKENBERG	NNP	B-NP	O
,	,	,	O	O
FLORENTINO	FLORENTINO	NNP	B-NP	O
MOSE	MOSE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Wheezing	Wheeze	VBG	B-VP	O
BACLOFEN	BACLOFEN	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
KLONOPIN	KLONOPIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLONAZEPAM	CLONAZEPAM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FOLATE	FOLATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FOLIC	FOLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LABETALOL	LABETALOL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
800	800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-VP	O
D	D	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
BECLOMETHASONE	BECLOMETHASONE	NN	I-NP	O
DIPROPIONATE	DIPROPIONATE	NN	I-NP	O
160	160	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
puff	puff	NN	I-NP	O
of	of	IN	B-PP	O
80mcg	80mcg	CD	B-NP	O
inhaler	inhaler	NN	I-NP	O
LIDODERM	LIDODERM	NNP	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
LIDOCAINE	LIDOCAINE	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
EA	EA	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-NP	O
one	one	CD	I-NP	O
patch	patch	NN	I-NP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
LOTRIMIN	LOTRIMIN	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
tinea	tinea	NN	B-NP	O
pedis	pedis	NN	I-NP	O
-	-	HYPH	B-ADVP	O
between	between	IN	B-PP	O
toes	toe	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/6/06	2/6/06	CD	B-NP	O
by	by	IN	B-PP	O
PULLUS	PULLUS	NNP	B-NP	O
,	,	,	O	O
JAY	JAY	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
topical	topical	JJ	B-NP	B-protein
LIPITOR	LIPITOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
DICLOXACILLIN	DICLOXACILLIN	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
10	10	CD	I-NP	I-protein
Days	Day	NNPS	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
1/3	1/3	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
PROTONIX	PROTONIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	I-protein
40	40	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
COUMADIN	COUMADIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
WARFARIN	WARFARIN	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Do	Do	NNP	B-NP	O
NOT	NOT	NN	I-NP	O
take	take	VBP	B-VP	O
tonight	tonight	NN	B-NP	O
9/17	9/17	CD	B-NP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
tomorrow	tomorrow	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
advise	advise	VB	I-VP	O
when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/1/06	10/1/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Activity	Activity	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Saiz	Saiz	NNP	I-NP	O
PCP	PCP	NN	I-NP	O
12/10/06	12/10/06	CD	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	SYM	I-NP	O
10	10	CD	I-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lund	Lund	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
-	-	HYPH	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
CH	CH	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
304-349-2431	304-349-2431	CD	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
cellulitis	cellulitis	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
Cl	Cl	NN	I-NP	O
difficile	difficile	NN	I-NP	O
in	in	IN	B-PP	O
stool	stool	NN	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
RLE	RLE	RB	B-NP	O
1996	1996	CD	I-NP	O
s/p	s/p	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	B-DNA
LLE	LLE	NN	I-NP	I-DNA
6/11/02	6/11/02	CD	I-NP	I-DNA
.	.	.	O	O

increased	increase	VBN	B-NP	O
lipids	lipid	NNS	I-NP	O
.	.	.	O	O

CRI	CRI	NN	B-NP	O
.	.	.	O	O

OSA	OSA	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
c-pap	c-pap	NN	B-NP	B-DNA
.	.	.	O	O

h/o	h/o	NN	B-NP	O
hemorrhagic	hemorrhagic	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
,	,	,	O	O
L-thalamic	L-thalamic	JJ	B-ADJP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
RLE	RLE	NN	I-NP	O
tendon	tendon	NN	I-NP	O
release	release	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
proteinuria	proteinuria	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
venous	venous	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
otitis	otitis	NN	I-NP	O
externa	externa	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
otitis	otitis	NN	I-NP	O
externa	externa	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OSA	OSA	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LENIs	LENIs	NNP	I-NP	O
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Fever	Fever	RB	B-ADVP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
swelling	swell	VBG	B-VP	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
44M	44M	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
R-sided	R-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
s/p	s/p	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	O
p/w	p/w	NN	I-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
10/5	10/5	CD	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
states	state	NNS	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
this	this	DT	B-NP	O
large	large	JJ	I-NP	O
.	.	.	O	O

Started	Start	VBD	B-VP	O
very	very	RB	B-ADVP	O
abruptly	abruptly	RB	I-ADVP	O
and	and	CC	O	O
progressed	progress	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
leg	leg	NN	I-NP	O
not	not	RB	B-VP	O
affected	affect	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
trauma	trauma	NN	I-NP	O
or	or	CC	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
otitis	otitis	NN	B-NP	O
externa	externa	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
chronically	chronically	RB	B-ADJP	O
wheezy	wheezy	JJ	I-ADJP	O
.	.	.	O	O

****	****	SYM	O	O
ED	ED	NN	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
LENI	LENI	NN	B-NP	O
's	'	VBZ	B-VP	O
no	no	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
ancef	ancef	NN	I-NP	O
given	give	VBN	B-VP	O
.	.	.	O	O

Nebs	Neb	NNS	B-NP	O
.	.	.	O	O

NS	NS	NN	B-NP	O
500cc	500cc	CD	I-NP	O
bolus	bolus	NN	I-NP	O
for	for	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
cre	cre	NN	I-NP	B-protein
2.9	2.9	CD	I-NP	I-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
3.7	3.7	CD	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
klonopin	klonopin	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
neurontin	neurontin	NN	B-NP	B-protein
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
protonix	protonix	NN	B-NP	O
,	,	,	O	O
CA+D	CA+D	NN	B-NP	B-protein
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
Wheelchair	Wheelchair	NNP	B-NP	O
bound	bind	VBD	B-VP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
home	home	NN	B-NP	O
aide	aide	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tob	tob	NN	I-NP	B-protein
or	or	CC	I-NP	O
ETOH	ETOH	NN	I-NP	B-protein
****	****	SYM	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T99	T99	NN	B-NP	O
.4	.4	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
105/51	105/51	CD	I-NP	I-DNA
,	,	,	O	O
P72	P72	NN	B-NP	B-protein
,	,	,	O	O
99RA	99RA	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
+	+	SYM	I-NP	O
RLE	RLE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Healed	Heal	VBN	B-NP	O
ulcer	ulcer	NN	I-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Fresh	Fresh	JJ	B-NP	O
abrasion	abrasion	NN	I-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	B-protein
Studies/LABS	Studies/LABS	NN	I-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	B-protein
3.7	3.7	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
2.1-2	2.1-2	CD	I-NP	O
.9	.9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	B-NP	O
31-36	31-36	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
LENI	LENI	NNP	B-NP	O
's	'	VBZ	B-VP	O
no	no	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
clot	clot	NN	I-NP	O
****	****	SYM	B-VP	O
Hosptial	Hosptial	JJ	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
45M	45M	NN	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
RLE	RLE	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
otitis	otitis	NN	B-NP	O
externa	externa	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cellulitis	Cellulitis	NN	I-NP	O
:	:	:	O	O
Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
nafcillin	nafcillin	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
elevation	elevation	NN	I-NP	O
.	.	.	O	O

Changed	Change	VBN	B-VP	O
to	to	TO	B-VP	O
po	po	VB	I-VP	O
diclox	diclox	NN	B-NP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
10days	10day	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Renal	Renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
:	:	:	O	O
Most	Most	JJS	B-ADJP	O
likely	likely	RB	I-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
-	-	HYPH	O	O
responded	respond	VBN	B-VP	O
to	to	TO	B-PP	O
IVF	IVF	NN	B-NP	B-protein
.	.	.	O	O

Cr	Cr	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Otitis	Otitis	NNP	I-NP	O
externa	externa	NN	I-NP	O
:	:	:	O	O
Vosol	Vosol	NN	B-NP	B-protein
HC	HC	NN	I-NP	I-protein
4drops	4drop	VBZ	B-VP	O
QID	QID	NN	B-NP	B-protein
given	give	VBN	B-PP	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
-LRB-	-LRB-	HYPH	B-NP	O
80s/50	80s/50	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
2/2	2/2	CD	I-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
.	.	.	O	O

IVF	IVF	NN	B-NP	O
bolus	bolus	NN	I-NP	O
given	give	VBN	B-VP	O
and	and	CC	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
labetalol	labetalol	NN	I-NP	O
with	with	IN	B-PP	O
holding	hold	VBG	B-VP	O
parameters	parameter	NNS	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
slightly	slightly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
so	so	RB	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
restarted	restart	VBD	B-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
CPAP	CPAP	NN	B-NP	B-protein
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
3.5	3.5	CD	I-NP	I-protein
-	-	HYPH	O	O
holding	hold	VBG	B-VP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	O	O
restart	restart	VB	B-VP	O
when	when	WRB	B-ADVP	O
<	<	SYM	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
Tinea	Tinea	NNP	B-NP	O
pedis	pedis	AFX	B-NP	O
-	-	HYPH	I-NP	O
lotrim	lotrim	JJ	I-NP	O
lotion	lotion	NN	I-NP	O
started	start	VBD	B-VP	O
BID	BID	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

PAIN	PAIN	NN	B-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sharplin	Sharplin	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
outpt	outpt	JJ	I-NP	O
pain	pain	NN	I-NP	O
doctor	doctor	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
baclofen	baclofen	NN	B-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
pump	pump	NN	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
despite	despite	IN	B-PP	O
it	it	PRP	B-NP	O
not	not	RB	B-VP	O
working	work	VBG	I-VP	O
because	because	IN	B-SBAR	O
pt	pt	NN	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
surgery	surgery	NN	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
it	it	PRP	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Fever	Fever	RB	B-ADVP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
swelling	swell	VBG	B-VP	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
44M	44M	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
R-sided	R-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
s/p	s/p	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	O
p/w	p/w	NN	I-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
10/5	10/5	CD	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
states	state	NNS	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
this	this	DT	B-NP	O
large	large	JJ	I-NP	O
.	.	.	O	O

Started	Start	VBD	B-VP	O
very	very	RB	B-ADVP	O
abruptly	abruptly	RB	I-ADVP	O
and	and	CC	O	O
progressed	progress	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
leg	leg	NN	I-NP	O
not	not	RB	B-VP	O
affected	affect	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
trauma	trauma	NN	I-NP	O
or	or	CC	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
otitis	otitis	NN	B-NP	O
externa	externa	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
chronically	chronically	RB	B-ADJP	O
wheezy	wheezy	JJ	I-ADJP	O
.	.	.	O	O

****	****	SYM	O	O
ED	ED	NN	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
LENI	LENI	NN	B-NP	O
's	'	VBZ	B-VP	O
no	no	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
ancef	ancef	NN	I-NP	O
given	give	VBN	B-VP	O
.	.	.	O	O

Nebs	Neb	NNS	B-NP	O
.	.	.	O	O

NS	NS	NN	B-NP	O
500cc	500cc	CD	I-NP	O
bolus	bolus	NN	I-NP	O
for	for	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
cre	cre	NN	I-NP	B-protein
2.9	2.9	CD	I-NP	I-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
3.7	3.7	CD	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
klonopin	klonopin	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
neurontin	neurontin	NN	B-NP	B-protein
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
protonix	protonix	NN	B-NP	O
,	,	,	O	O
CA+D	CA+D	NN	B-NP	B-protein
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
Wheelchair	Wheelchair	NNP	B-NP	O
bound	bind	VBD	B-VP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
home	home	NN	B-NP	O
aide	aide	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tob	tob	NN	I-NP	B-protein
or	or	CC	I-NP	O
ETOH	ETOH	NN	I-NP	B-protein
****	****	SYM	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T99	T99	NN	B-NP	O
.4	.4	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
105/51	105/51	CD	I-NP	I-DNA
,	,	,	O	O
P72	P72	NN	B-NP	B-protein
,	,	,	O	O
99RA	99RA	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
+	+	SYM	I-NP	O
RLE	RLE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Healed	Heal	VBN	B-NP	O
ulcer	ulcer	NN	I-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Fresh	Fresh	JJ	B-NP	O
abrasion	abrasion	NN	I-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	B-protein
Studies/LABS	Studies/LABS	NN	I-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	B-protein
3.7	3.7	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
2.1-2	2.1-2	CD	I-NP	O
.9	.9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	B-NP	O
31-36	31-36	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
LENI	LENI	NNP	B-NP	O
's	'	VBZ	B-VP	O
no	no	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
clot	clot	NN	I-NP	O
****	****	SYM	B-VP	O
Hosptial	Hosptial	JJ	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
45M	45M	NN	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
RLE	RLE	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
otitis	otitis	NN	B-NP	O
externa	externa	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cellulitis	Cellulitis	NN	I-NP	O
:	:	:	O	O
Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
nafcillin	nafcillin	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
elevation	elevation	NN	I-NP	O
.	.	.	O	O

Changed	Change	VBN	B-VP	O
to	to	TO	B-VP	O
po	po	VB	I-VP	O
diclox	diclox	NN	B-NP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
10days	10day	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Renal	Renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
:	:	:	O	O
Most	Most	JJS	B-ADJP	O
likely	likely	RB	I-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
-	-	HYPH	O	O
responded	respond	VBN	B-VP	O
to	to	TO	B-PP	O
IVF	IVF	NN	B-NP	B-protein
.	.	.	O	O

Cr	Cr	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Otitis	Otitis	NNP	I-NP	O
externa	externa	NN	I-NP	O
:	:	:	O	O
Vosol	Vosol	NN	B-NP	B-protein
HC	HC	NN	I-NP	I-protein
4drops	4drop	VBZ	B-VP	O
QID	QID	NN	B-NP	B-protein
given	give	VBN	B-PP	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
-LRB-	-LRB-	HYPH	B-NP	O
80s/50	80s/50	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
2/2	2/2	CD	I-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
.	.	.	O	O

IVF	IVF	NN	B-NP	O
bolus	bolus	NN	I-NP	O
given	give	VBN	B-VP	O
and	and	CC	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
labetalol	labetalol	NN	I-NP	O
with	with	IN	B-PP	O
holding	hold	VBG	B-VP	O
parameters	parameter	NNS	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
slightly	slightly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
so	so	RB	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
restarted	restart	VBD	B-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
CPAP	CPAP	NN	B-NP	B-protein
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
3.5	3.5	CD	I-NP	I-protein
-	-	HYPH	O	O
holding	hold	VBG	B-VP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	O	O
restart	restart	VB	B-VP	O
when	when	WRB	B-ADVP	O
<	<	SYM	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
8/25	8/25	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
Tinea	Tinea	NNP	B-NP	O
pedis	pedis	AFX	B-NP	O
-	-	HYPH	I-NP	O
lotrim	lotrim	JJ	I-NP	O
lotion	lotion	NN	I-NP	O
started	start	VBD	B-VP	O
BID	BID	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

PAIN	PAIN	NN	B-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jevtic	Jevtic	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
outpt	outpt	JJ	I-NP	O
pain	pain	NN	I-NP	O
doctor	doctor	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
baclofen	baclofen	NN	B-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
pump	pump	NN	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
despite	despite	IN	B-PP	O
it	it	PRP	B-NP	O
not	not	RB	B-VP	O
working	work	VBG	I-VP	O
because	because	IN	B-SBAR	O
pt	pt	NN	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
surgery	surgery	NN	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
it	it	PRP	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Addended	Addended	NNP	B-NP	O
Koogler	Koogler	NNP	I-NP	O
,	,	,	O	O
Vicente	Vicente	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
10/1/06	10/1/06	CD	B-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Please	Please	NN	B-NP	B-protein
take	take	VBP	B-VP	O
dicloxacillin	dicloxacillin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
4x/day	4x/day	NN	I-NP	O
for	for	IN	B-PP	O
10days	10day	NNS	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
keep	keep	VB	I-VP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
until	until	IN	B-PP	O
your	your	PRP$	B-NP	O
infection	infection	NN	I-NP	O
heals	heal	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
take	take	VB	I-VP	O
norvasc	norvasc	RB	B-ADVP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Foreman	Foreman	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
advise	advise	VB	I-VP	O
you	you	PRP	B-NP	O
on	on	IN	B-PP	O
whether	whether	IN	B-SBAR	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
it	it	PRP	B-NP	O
or	or	CC	O	O
not	not	RB	O	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
tonight	tonight	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
tomorrow	tomorrow	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
advise	advise	VB	I-VP	O
you	you	PRP	B-NP	O
on	on	IN	B-PP	O
when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Continue	Continue	JJ	B-NP	O
lotrim	lotrim	JJ	I-NP	O
lotion	lotion	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
between	between	IN	B-PP	O
your	your	PRP$	B-NP	O
toes	toe	NNS	I-NP	O
for	for	IN	B-PP	O
athlete	athlete	NN	B-NP	O
's	's	POS	B-NP	O
foot	foot	NN	I-NP	O
until	until	IN	B-SBAR	O
healed	heal	VBN	B-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Marchessault	Marchessault	NNP	I-NP	O
or	or	CC	O	O
come	come	VB	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
increased	increase	VBD	B-VP	O
swelling	swelling	NN	B-NP	O
or	or	CC	I-NP	O
reddness	reddness	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	B-cell_type
VNA	VNA	NN	I-NP	I-cell_type
*	*	SYM	B-NP	I-cell_type
Medication	Medication	NNP	I-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
checks	check	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
draw	draw	NN	I-NP	O
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
into	into	IN	B-PP	O
UMC	UMC	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
304-349-2431	304-349-2431	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
PCP	PCP	NN	B-NP	O
*	*	SYM	I-NP	O
Norvasc	Norvasc	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

Restart	Restart	NN	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO/PLAN	DO/PLAN	NN	B-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
VNA	VNA	NN	I-NP	O
*	*	SYM	B-NP	O
Medication	Medication	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
checks	check	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
draw	draw	NN	I-NP	O
on	on	IN	B-PP	O
8/25	8/25	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
into	into	IN	B-PP	O
TLB	TLB	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
304-349-2431	304-349-2431	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
PCP	PCP	NN	B-NP	O
*	*	SYM	I-NP	O
Norvasc	Norvasc	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

Restart	Restart	NN	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Addended	Addended	NNP	B-NP	O
Trezza	Trezza	NNP	I-NP	O
,	,	,	O	O
Robbie	Robbie	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
10/1/06	10/1/06	CD	B-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
PM	PM	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CALAIS	CALAIS	NNP	B-NP	O
,	,	,	O	O
JODY	JODY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/1/06	10/1/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
17	17	CD	B-NP	O
AM	AM	NNP	I-NP	O
Addended	Addended	NNP	I-NP	O
Canete	Canete	NNP	I-NP	O
,	,	,	O	O
Richard	Richard	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
10/1/06	10/1/06	CD	B-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
PM	PM	NNP	I-NP	O
Addended	Addended	NNP	I-NP	O
Sauler	Sauler	NNP	I-NP	O
,	,	,	O	O
Abraham	Abraham	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
10/1/06	10/1/06	CD	B-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

